Artykuły w czasopismach na temat „Trials”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Trials”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Seow, Hsien-Yeang, Patrick Whelan, Mark N. Levine, Kathryn Cowan, Barbara Lysakowski, Brenda Kowaleski, Anne Snider, Rebecca Y. Xu i Andrew Arnold. "Funding Oncology Clinical Trials: Are Cooperative Group Trials Sustainable?" Journal of Clinical Oncology 30, nr 13 (1.05.2012): 1456–61. http://dx.doi.org/10.1200/jco.2011.37.2698.
Pełny tekst źródłaVan Der Weyden, Martin B. "Trials on trial". Medical Journal of Australia 175, nr 5 (wrzesień 2001): 241. http://dx.doi.org/10.5694/j.1326-5377.2001.tb143553.x.
Pełny tekst źródłaNelson, Mark. "Trials on trial". New Scientist 209, nr 2800 (luty 2011): 30. http://dx.doi.org/10.1016/s0262-4079(11)60384-9.
Pełny tekst źródłaVulto, Arnold G. "Clinical trials on trial". European Journal of Hospital Pharmacy 19, nr 4 (sierpień 2012): 347. http://dx.doi.org/10.1136/ejhpharm-2012-000180.
Pełny tekst źródłaPimentel, Leonardo Duarte, Claudio Horst Bruckner, Candida Elisa Manfio, Sérgio Yoshimitsu Motoike i Hermínia Emília Prieto Martinez. "SUBSTRATE, LIME, PHOSPHORUS AND TOPDRESS FERTILIZATION IN MACAW PALM SEEDLING PRODUCTION". Revista Árvore 40, nr 2 (kwiecień 2016): 235–44. http://dx.doi.org/10.1590/0100-67622016000200006.
Pełny tekst źródłade Vries, Ymkje Anna, Annelieke M. Roest, Erick H. Turner i Peter de Jonge. "Hiding negative trials by pooling them: a secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trials". Psychological Medicine 49, nr 12 (28.09.2018): 2020–26. http://dx.doi.org/10.1017/s0033291718002805.
Pełny tekst źródłaKim, Daniel J., Dan Otap, Nora Ruel, Naveen Gupta, Naveed Khan i Tanya Dorff. "NCI–Clinical Trial Accrual in a Community Network Affiliated with a Designated Cancer Center". Journal of Clinical Medicine 9, nr 6 (24.06.2020): 1970. http://dx.doi.org/10.3390/jcm9061970.
Pełny tekst źródłaFoster, Henry H. "TRIAL MARRIAGES AND DIVORCE TRIALS". Family Court Review 11, nr 1 (15.03.2005): 1–7. http://dx.doi.org/10.1111/j.174-1617.1973.tb01183.x.
Pełny tekst źródłaHarman, Chloë. "Putting clinical trials on trial". Nature Reviews Nephrology 5, nr 6 (czerwiec 2009): 301. http://dx.doi.org/10.1038/nrneph.2009.89.
Pełny tekst źródłaMIZUSHIMA, YUTAKA. "New trials of trial cases." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 29, nr 1/2 (1998): 1–6. http://dx.doi.org/10.3999/jscpt.29.1.
Pełny tekst źródłaPalca, J. "Government ddI trials on trial". Science 246, nr 4935 (8.12.1989): 1244. http://dx.doi.org/10.1126/science.2511632.
Pełny tekst źródłaRenfro, Lindsay A., Axel M. Grothey, James Paul, Irene Floriani, Franck Bonnetain, Donna Niedzwiecki, Takeharu Yamanaka, Ioannis Souglakos, Greg Yothers i Daniel J. Sargent. "Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration. Projecting Analysis Dates for the IDEA Collaboration". Forum of Clinical Oncology 5, nr 2 (10.12.2014): 1–7. http://dx.doi.org/10.2478/fco-2014-0006.
Pełny tekst źródłaSydes, Matthew R., Yolanda Barbachano, Louise Bowman, Tom Denwood, Andrew Farmer, Steph Garfield-Birkbeck, Martin Gibson i in. "Realising the full potential of data-enabled trials in the UK: a call for action". BMJ Open 11, nr 6 (czerwiec 2021): e043906. http://dx.doi.org/10.1136/bmjopen-2020-043906.
Pełny tekst źródłaLebensburger, Jeffrey D., Lauren Pair, Lee Hilliard i Thomas H. Howard. "A Systematic Review Of All Interventional Sickle Cell Trials Registered At Clinicaltrials.Gov". Blood 122, nr 21 (15.11.2013): 2990. http://dx.doi.org/10.1182/blood.v122.21.2990.2990.
Pełny tekst źródłaNeel, Dylan, David Stephen Shulman i Steven G. DuBois. "Sponsorship of pediatric oncology interventional trials." Journal of Clinical Oncology 37, nr 15_suppl (20.05.2019): 10044. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.10044.
Pełny tekst źródłaBansal, R., R. Khan, N. Gimpaya, M. A. Scaffidi, K. Elsolh, Y. Verma, J. Li i S. C. Grover. "A160 PREVALENCE OF OUTCOME SWITCHING AMONG PUBLISHED PHASE 3 INTERVENTIONAL TRIALS FOR INFLAMMATORY BOWEL DISEASE THERAPEUTICS". Journal of the Canadian Association of Gastroenterology 4, Supplement_1 (1.03.2021): 167–68. http://dx.doi.org/10.1093/jcag/gwab002.158.
Pełny tekst źródłaPrasad, E. Maruthi, i Shih-Ya Hung. "Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update". Pharmaceuticals 14, nr 8 (25.07.2021): 717. http://dx.doi.org/10.3390/ph14080717.
Pełny tekst źródłaCicchetti, Americo, Domenico Addesso, Filippo Elvino Leone, Antonino Amato, Luca Angerame, Angelo D'Aversa, Mario Fraticelli i in. "Valorization of clinical trials from the Italian National Health Service perspective: definition and first application of a model to estimate avoided costs". Global & Regional Health Technology Assessment 7, nr 1 (16.06.2020): 26–32. http://dx.doi.org/10.33393/grhta.2020.709.
Pełny tekst źródłaMoyé, Lemuel A., i Anita Deswal. "Trials within Trials". Controlled Clinical Trials 22, nr 6 (grudzień 2001): 605–19. http://dx.doi.org/10.1016/s0197-2456(01)00180-5.
Pełny tekst źródłaHamm, Caroline M., Krista Naccarato, Stephen Sundquist, Suzana Kovacevic, Youshaa El-Abed i Janet Dancey. "Clinical trials navigator: Patient-centered access to clinical trials." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): e14024-e14024. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e14024.
Pełny tekst źródłaGrayling, Michael J., James MS Wason i Adrian P. Mander. "Group sequential designs for stepped-wedge cluster randomised trials". Clinical Trials 14, nr 5 (27.06.2017): 507–17. http://dx.doi.org/10.1177/1740774517716937.
Pełny tekst źródłaNakamura, Kenichi, i Taro Shibata. "Regulatory changes after the enforcement of the new Clinical Trials Act in Japan". Japanese Journal of Clinical Oncology 50, nr 4 (27.02.2020): 399–404. http://dx.doi.org/10.1093/jjco/hyaa028.
Pełny tekst źródłaShah, Harshal, Akash Mishra, Michael Gouzoulis, Netanel Ben-Shalom i Randy D'Amico. "QLTI-06. CHARACTERISTICS OF TERMINATED GLIOBLASTOMA-RELATED CLINICAL TRIALS: A REVIEW OF THE CLINICALTRIALS.GOV DATABASE". Neuro-Oncology 24, Supplement_7 (1.11.2022): vii235. http://dx.doi.org/10.1093/neuonc/noac209.908.
Pełny tekst źródłaJones, Marcus, Marin Harbur i Ken J. Moore. "Automating Uniformity Trials to Optimize Precision of Agronomic Field Trials". Agronomy 11, nr 6 (21.06.2021): 1254. http://dx.doi.org/10.3390/agronomy11061254.
Pełny tekst źródłaAbbiss, Chris R., Kevin G. Thompson, Marcin Lipski, Tim Meyer i Sabrina Skorski. "Difference in Pacing Between Time- and Distance-Based Time Trials in Trained Cyclists". International Journal of Sports Physiology and Performance 11, nr 8 (listopad 2016): 1018–23. http://dx.doi.org/10.1123/ijspp.2015-0613.
Pełny tekst źródłaCooper, Cindy L., Amy Whitehead, Edward Pottrill, Steven A. Julious i Stephen J. Walters. "Are pilot trials useful for predicting randomisation and attrition rates in definitive studies: A review of publicly funded trials". Clinical Trials 15, nr 2 (23.01.2018): 189–96. http://dx.doi.org/10.1177/1740774517752113.
Pełny tekst źródłaDu, Jingcheng, Qing Wang, Jingqi Wang, Prerana Ramesh, Yang Xiang, Xiaoqian Jiang i Cui Tao. "COVID-19 trial graph: a linked graph for COVID-19 clinical trials". Journal of the American Medical Informatics Association 28, nr 9 (24.04.2021): 1964–69. http://dx.doi.org/10.1093/jamia/ocab078.
Pełny tekst źródłaHao, Guo-Xiang, Xiao-Ling Wang, A.-Dong Shen, Evelyne Jacqz-Aigrain i Wei Zhao. "PEDIATRIC DRUG TRIALS IN CHINA". Archives of Disease in Childhood 101, nr 1 (14.12.2015): e1.12-e1. http://dx.doi.org/10.1136/archdischild-2015-310148.2.
Pełny tekst źródłaWeinberg, Jeffrey. "Clinical Trials in Progress: ROADS Trial". ONCOLOGY, nr 3508 (sierpień 2021): 495. http://dx.doi.org/10.46883/onc.2021.3508.0495.
Pełny tekst źródłaDean, Rachel S. "Veterinary clinical trials are on trial". Veterinary Record 181, nr 8 (18.08.2017): 193–94. http://dx.doi.org/10.1136/vr.j3867.
Pełny tekst źródłaRokhsefat, Sana, Deanna E. Morra, Martin Offringa, Lisa M. Askie i Lauren E. Kelly. "Trial registration in pediatric surgery trials". Journal of Pediatric Surgery 53, nr 7 (lipiec 2018): 1273–79. http://dx.doi.org/10.1016/j.jpedsurg.2017.10.049.
Pełny tekst źródłaCurtis, John J., i Bruce Kaplan. "Transplant Immunosuppressive Drug Trials on Trial". American Journal of Transplantation 4, nr 5 (maj 2004): 671–72. http://dx.doi.org/10.1111/j.1600-6143.2004.00474.x.
Pełny tekst źródłaLudmir, Ethan B., Walker Mainwaring, Austin B. Miller, Timothy Lin, Amit Jethanandani, Andres F. Espinoza i Clifton David Fuller. "Age disparities among cancer clinical trial participants: The role of industry sponsorship." Journal of Clinical Oncology 37, nr 15_suppl (20.05.2019): 11527. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.11527.
Pełny tekst źródłaAllan, C., A. Chapman, C. Parker, A. Boltong i J. Millar. "Missing Evidence: Exploring Unpublished Trials in Victoria, Australia". Journal of Global Oncology 4, Supplement 2 (1.10.2018): 96s. http://dx.doi.org/10.1200/jgo.18.28700.
Pełny tekst źródłaYao, Bin, Kathy Zhang, Yannis Jemiai i David D. Chang. "Interim decisions in oncology trials." Journal of Clinical Oncology 31, nr 15_suppl (20.05.2013): e12530-e12530. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e12530.
Pełny tekst źródłaKnowles, Rachel L., Kam Pou Ha, Julia Mueller, Frances Rawle i Rosa Parker. "Challenges for funders in monitoring compliance with policies on clinical trials registration and reporting: analysis of funding and registry data in the UK". BMJ Open 10, nr 2 (luty 2020): e035283. http://dx.doi.org/10.1136/bmjopen-2019-035283.
Pełny tekst źródłaWong, Karen, Rachel Phelan, Eija Kalso, Imelda Galvin, David Goldstein, Srinivasa Raja i Ian Gilron. "Antidepressant Drugs for Prevention of Acute and Chronic Postsurgical Pain". Anesthesiology 121, nr 3 (1.09.2014): 591–608. http://dx.doi.org/10.1097/aln.0000000000000307.
Pełny tekst źródłaBennette, Caroline Savage, Nathan Coleman Nussbaum, Melissa D. Curtis i Neal J. Meropol. "Using real-world cohorts to assess the generalizability and relevance of randomized clinical trials (RCTs)." Journal of Clinical Oncology 37, nr 15_suppl (20.05.2019): 6540. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.6540.
Pełny tekst źródłaEllaway-Barnard, Christopher, Hannah Killick, Guy Peryer, Jane L. Cross i Toby O. Smith. "The association between registration status and reported outcomes in physiotherapy randomised controlled trials". International Journal of Therapy and Rehabilitation 27, nr 3 (2.03.2020): 1–15. http://dx.doi.org/10.12968/ijtr.2019.0023.
Pełny tekst źródłaHoderlein, Xenia, Anne M. Moseley i Mark R. Elkins. "Citation of prior research has increased in introduction and discussion sections with time: A survey of clinical trials in physiotherapy". Clinical Trials 14, nr 4 (19.03.2017): 372–80. http://dx.doi.org/10.1177/1740774517699821.
Pełny tekst źródłaGoldenberg, Joshua Z., i Cynthia A. Wenner. "A Novel N of 1 Trial Design and Proposed Utility in Complementary and Alternative Medicine Research". Journal of Evidence-Based Complementary & Alternative Medicine 17, nr 2 (22.03.2012): 126–30. http://dx.doi.org/10.1177/2156587212437556.
Pełny tekst źródłaLevine, Deborah J., i Fernando Torres. "Clinical Trials Update". Advances in Pulmonary Hypertension 12, nr 2 (1.01.2013): 53–54. http://dx.doi.org/10.21693/1933-088x-12.2.53.
Pełny tekst źródłaShowell, Marian, Sam Buckman, Slavica Berber, Nada Ata Allah, Ben Patterson, Samantha Cole, Cynthia Farquhar i Vanessa Jordan. "Publication bias in trials registered in the Australian New Zealand Clinical Trials Registry: Is it a problem? A cross-sectional study". PLOS ONE 18, nr 1 (5.01.2023): e0279926. http://dx.doi.org/10.1371/journal.pone.0279926.
Pełny tekst źródłaUdayakumar, Suji, Sasha Thomson, Albiruni Ryan Abdul Razak i Kelvin K. Chan. "Do early phase trials predict clinical efficacy in subsequent phase III biomarker-enriched randomized trials?" Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): 3152. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.3152.
Pełny tekst źródłaUnger, Joseph M., William E. Barlow, Catherine M. Tangen, Scott David Ramsey, Ian Murchie Thompson, Eric A. Klein, Michael Leo LeBlanc i in. "The scientific impact and value of large, NCI-sponsored randomized phase III cancer prevention trials." Journal of Clinical Oncology 35, nr 15_suppl (20.05.2017): 1541. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1541.
Pełny tekst źródłaPinto, Rafael Zambelli, Mark R. Elkins, Anne M. Moseley, Catherine Sherrington, Robert D. Herbert, Christopher G. Maher, Paulo H. Ferreira i Manuela L. Ferreira. "Many Randomized Trials of Physical Therapy Interventions Are Not Adequately Registered: A Survey of 200 Published Trials". Physical Therapy 93, nr 3 (1.03.2013): 299–309. http://dx.doi.org/10.2522/ptj.20120206.
Pełny tekst źródłaMoffitt, K., R. D. Marsh i C. Hudson. "The case for proactive, collaborative data-updating in a statewide cancer clinical trial matching service". Journal of Clinical Oncology 25, nr 18_suppl (20.06.2007): 6570. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.6570.
Pełny tekst źródłaHsiue, Emily Han-Chung, Thomas J. Moore i G. Caleb Alexander. "Estimated costs of pivotal trials for U.S. Food and Drug Administration–approved cancer drugs, 2015–2017". Clinical Trials 17, nr 2 (29.02.2020): 119–25. http://dx.doi.org/10.1177/1740774520907609.
Pełny tekst źródłaGraham, H. Kerr. "The trials of trials". Developmental Medicine & Child Neurology 49, nr 3 (marzec 2007): 163. http://dx.doi.org/10.1111/j.1469-8749.2007.00163.x.
Pełny tekst źródłaHenegan, John Clark, i Francis Garner Bell. "Variance of mean baseline health-related quality of life across phase III clinical trials in metastatic renal cell carcinoma." Journal of Clinical Oncology 40, nr 6_suppl (20.02.2022): 329. http://dx.doi.org/10.1200/jco.2022.40.6_suppl.329.
Pełny tekst źródła